Seizure medication and mental health risk
Part of Brain & nervous system clinical trials.
This study looks at whether the first seizure medication you are prescribed might affect your risk of developing mental health issues later. It uses insurance records to compare different medications and their effects on mood and anxiety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be covered by French national health insurance (Sécurité sociale).
- You must be receiving your first-ever medication for seizures or epilepsy.
- You must not have had any mental health condition (like anxiety, depression, or bipolar disorder) in the year before starting this medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people ages 18 to 65 after they have a first seizure that is not clearly triggered. It also compares them with healthy volunteers to better understand what might predict whether seizures come back.
This study uses a brain wave test (EEG) to see if it can predict how well anti-seizure medication will work for people newly diagnosed with epilepsy. It may help doctors choose the right medication sooner.
This study looks at whether checking and treating heart and blood vessel risk factors can help people who start having seizures after age 50. It includes two parts: one that adds a risk check to your regular care, and one that uses your medical records to learn more about this condition.
This study looks at what happens when people with epilepsy stop their seizure medications. The goal is to see if it's safe to stop after being seizure-free for a while, and to help patients and doctors make better decisions.
This study looks at what factors can make seizures happen after a first stroke. It may help doctors identify who is more at risk so future care can be better targeted.
This study measures how much epilepsy medicine (lamotrigine, levetiracetam, or oxcarbazepine) your body absorbs during pregnancy and breastfeeding. It may help doctors better understand dosing and safety during these times.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.